What is the confirmed 2025 market size and projected 2035 value for the veterinary endoscopes market?
The market was valued at USD 336.8 million in 2025 and is forecast to reach USD 619.2 million by 2035 at a 7.0% CAGR. Flexible video endoscopes are the dominant product category by revenue. Gastrointestinal endoscopy is the highest-volume procedure application. Laparoscopy is the fastest-growing therapeutic endoscopy segment. Companion animals are the dominant species. Veterinary hospitals and specialist referral clinics are the primary end-users. North America holds the largest geographic share; Asia-Pacific is the fastest-growing region.

What drives laparoscopy as the fastest-growing veterinary endoscopy application?
Laparoscopic spay (ovariohysterectomy and ovariectomy), cryptorchid castration, liver biopsy, and prophylactic gastropexy — performed through 3–5mm port incisions rather than 10–20cm open incisions — are growing fastest by procedure volume from pet owner preference for minimally invasive approaches with reduced operative pain, smaller scars, and faster return to normal activity versus open abdominal surgery. Corporate specialist companion animal hospitals offering laparoscopic ovariohysterectomy command USD 400–800 premiums above conventional open spay fees, sustaining the economic justification for laparoscopic tower system investment of USD 25,000–60,000 per suite.

How does GI flexible endoscopy sustain the highest-volume endoscopic procedure application in companion animal practice?
Companion animal gastrointestinal endoscopy — oesophagoscopy, gastroscopy, duodenoscopy, colonoscopy, and foreign body retrieval — is the highest-volume endoscopic application because GI disease is one of the most common companion animal presenting complaints and foreign body ingestion is a frequent acute emergency. Each GI foreign body retrieval avoiding open gastrotomy or enterotomy generates USD 1,500–3,000 in specialist endoscopy fees while eliminating the recovery period of open abdominal surgery. Inflammatory bowel disease diagnosis requiring endoscopic mucosal biopsy sustains recurring GI endoscopy volume from the large chronic enteropathy companion animal population.

What is driving arthroscopy as the most rapidly developing orthopaedic endoscopy segment?
Arthroscopic joint surgery — enabling joint disease diagnosis and therapeutic intervention (OCD fragment removal, joint lavage, cruciate ligament assessment, synovial biopsy) through 2–3mm portal incisions — is growing from veterinary surgeon arthroscopy training programme graduate expansion, with ACVS residency programmes and CE courses increasing the board-certified and trained arthroscopist base. Equine arthroscopy — diagnosing and treating OCD in fetlock, hock, and stifle joints in performance horses — commands USD 5,000–15,000 per procedure, sustaining premium arthroscopy system investment at equine referral hospitals.

How does companion animal oncology screening affect endoscopic procedure demand?
Companion animal cancer screening platforms identifying confirmed GI tumours (colorectal cancer, gastric carcinoma, intestinal lymphoma) are generating endoscopic mucosal biopsy requirements for tumour tissue sampling and histological typing before treatment initiation. Each GI cancer screen-positive result generating an endoscopic biopsy represents additional endoscopy procedure volume from the growing pool of cancer-screening-identified companion animal oncology patients. Laparoscopic liver biopsy and laparoscopic-assisted intestinal biopsy for confirmed abdominal malignancy staging are also creating above-baseline laparoscopic procedure demand.

What is driving veterinary endoscope demand in Asia-Pacific markets?
Asia-Pacific companion animal endoscope demand is growing from the expansion of companion animal specialist hospital infrastructure in China, South Korea, and Japan — where corporate companion animal hospital chains are hiring and training board-certified and endoscopy-trained veterinary internists and surgeons who require endoscope systems for GI, laparoscopic, and arthroscopic procedures. The large gap between current companion animal endoscopic procedure availability and the growing companion animal patient population’s specialist care demand sustains above-global-average Asia-Pacific endoscope market growth.